Ovarian cancer patients, especially those in the advanced stage, often exhibit increased serum levels of PLAU and PLAUR [32, 33], but while its elevated level is linked to shorter progression-free and overall survival, it does not represent a standalone prognostic indicator [34]. This evidence concerns the gene PLAUR and ovarian carcinoma.